Crossref
Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy.
Journal of Chemical Health Risks · 29.04.2026
DOI: 10.52783/jchr.v16.i2.13541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Health Risks, online erschienen am 29.04.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy. Journal of Chemical Health Risks. https://doi.org/10.52783/jchr.v16.i2.13541
Vancouver
Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy. Journal of Chemical Health Risks. 2026. doi:10.52783/jchr.v16.i2.13541
BibTeX
@article{euvimed2026,
title = {Hypomethylating Agents and Epigenetic Biomarkers: Reprogramming Methylation Patterns in Cancer Therapy},
journal = {Journal of Chemical Health Risks},
year = {2026},
doi = {10.52783/jchr.v16.i2.13541}
}
EUVIMED